I’ve spent years covering biotech – first as a business reporter and then as an analyst and stock picker.
So I know how the industry “works.” And I know what ignites biotech stocks … and fires off their biggest rallies. Creating the biggest windfalls for the folks who own them.
And the No. 1 “trigger” of all is the “Blockbuster Drug.”
You find the companies that control those blockbusters – you find them early – and you’ll pull down staggering gains.
Back in 2012, a tiny biotech firm created a new blood cancer drug – just as a slew of Big Pharma players were losing key patents. I recommended that tiny firm to my previous newsletter subscribers … and just a few years later that company was sold in a merger deal – and the folks who followed my reports pocketed gains of as much as 818%.
I’ve found an even-more-alluring opportunity now.
A new drug category has been launched. The two leaders can’t keep up with demand. And because the “Next Blockbuster” cycle just got underway, we’re talking about a wealth cycle that could last a decade.
These companies are already “big” – so no merger is needed for you to win.
You just need to buy the “right” companies … and go along for the ride.
In my latest free report in Stock Picker’s Corner (SPC), I identify the opportunity, some of the companies, and all you need to know.
You can access it here.
Disclaimer: The information published in Stock Picker’s Corner, also abbreviated at times as “SPC,” isn’t personalized financial advice or a specific investment recommendation and should not be interpreted as such. The content produced is intended for informational purposes only. The writers and team members of Stock Picker’s Corner are not investment advisors or financial planners, and you should consult your own professional before making any investment decisions. There is inherent risk involved with investing and financial decisions, and any investment decisions you make are solely your own decisions. Market outlooks, estimates, or projections should not be construed as actual events that may occur. While stats and figures are believed to be as accurate as possible from public information available at the time of publishing, the writers and team members of this publication do not make any warranties regarding the information’s accuracy. Neither the writers, team members, or affiliates accept any liability for any direct or indirect losses from the information contained herein. Team members, contractors, and guest contributors may own assets and stocks mentioned in Stock Picker’s Corner. By using this site or associated social media accounts, you are indicating your consent to our terms of use, and this disclaimer. All content published by Stock Picker’s Corner is copyrighted. Any unauthorized reproduction of any content published from Stock Picker’s Corner is strictly prohibited.
